Predictors of a non-response to prophylactic indomethacin for patent ductus arteriosus in preterm infants
Background: Preterm infants are recommended for prophylactic indomethacin (PIND) to promote closure of patent ductus arteriosus (PDA) and reduce morbidity and mortality. This study investigated the predictive factors of a non-response to PIND for PDA in preterm-birth infants. Methods: Consecutive pr...
Saved in:
Main Authors: | Masafumi Utsumi (Author), Noriko Motoki (Author), Saori Yokota (Author), Honami Kobayashi (Author), Shoko Yamazaki (Author), Yukihide Miyosawa (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patent Ductus Arteriosus in Preterm Infants
by: Jia-Yuh Chen
Published: (2012) -
Ibuprofen vs. indomethacin for persistent ductus arteriosus closure in preterm infants
by: Deny Salverra Yosy, et al.
Published: (2013) -
Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports
by: Shun Matsumura, et al.
Published: (2017) -
Risk factors for patent ductus arteriosus in preterm neonates
by: Novia Bernati, et al.
Published: (2014) -
THE MODERN VIEW ON PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS
by: Жанна Анатольевна Звягина, et al.
Published: (2018)